Drugs / R475
re-read 3 minutes ago

R475

Investigated by
Regeneron Pharmaceuticals · Sanofi

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01053702 — — Regeneron Pharmaceuticals Withdrawn No outcome recorded Stop: Business

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as R475 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01053702 ↗